|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-2-2
|
|
pubmed:abstractText |
Patients with liver cirrhosis have disturbances in the insulin-like growth factor I (IGF-I) system that favour insulin resistance and catabolism. High morbidity and mortality of such patients from infections may be related to further aggravation of this problem but human data are controversial. Here, the effect of lipopolysaccharide (LPS) endotoxin on the IGF system was studied in rats with cirrhosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0258-851X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
655-61
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19180987-Animals,
pubmed-meshheading:19180987-Bile Ducts,
pubmed-meshheading:19180987-Blood Glucose,
pubmed-meshheading:19180987-Endotoxins,
pubmed-meshheading:19180987-Female,
pubmed-meshheading:19180987-Insulin,
pubmed-meshheading:19180987-Insulin Resistance,
pubmed-meshheading:19180987-Insulin-Like Growth Factor Binding Protein 3,
pubmed-meshheading:19180987-Insulin-Like Growth Factor Binding Proteins,
pubmed-meshheading:19180987-Insulin-Like Growth Factor I,
pubmed-meshheading:19180987-Lipopolysaccharides,
pubmed-meshheading:19180987-Liver,
pubmed-meshheading:19180987-Liver Cirrhosis,
pubmed-meshheading:19180987-RNA, Messenger,
pubmed-meshheading:19180987-Rats,
pubmed-meshheading:19180987-Rats, Wistar
|
|
pubmed:articleTitle |
Effects of lipopolysaccharide endotoxin on the insulin-like growth factor I system in rats with cirrhosis.
|
|
pubmed:affiliation |
Department of Medicine V (Hepatology and Gastroenterology), Clinical Institute, Aarhus University Hospital, DK-8000 Aarhus C, Denmark. kltho@as.aaa.dk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
